Trxade Group Stock Net Asset
| MEDS Stock | USD 6.29 0.28 4.66% |
Trxade Group fundamentals help investors to digest information that contributes to Trxade's financial success or failures. It also enables traders to predict the movement of Trxade Stock. The fundamental analysis module provides a way to measure Trxade's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trxade stock.
Trxade | Net Asset |
Trxade Group Company Net Asset Analysis
Trxade's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Trxade Net Asset | 12.53 M |
Most of Trxade's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trxade Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Trxade Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Trxade is extremely important. It helps to project a fair market value of Trxade Stock properly, considering its historical fundamentals such as Net Asset. Since Trxade's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Trxade's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Trxade's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Trxade Total Assets
Total Assets |
|
Based on the recorded statements, Trxade Group has a Net Asset of 12.53 M. This is much higher than that of the Consumer Staples Distribution & Retail sector and significantly higher than that of the Consumer Staples industry. The net asset for all United States stocks is notably lower than that of the firm.
Trxade Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trxade's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Trxade could also be used in its relative valuation, which is a method of valuing Trxade by comparing valuation metrics of similar companies.Trxade is currently under evaluation in net asset category among related companies.
Trxade Institutional Holders
Institutional Holdings refers to the ownership stake in Trxade that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Trxade's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Trxade's value.| Shares | Tower Research Capital Llc | 2023-12-31 | 2.1 K | Ronald Blue Trust, Inc. | 2023-12-31 | 357 | Qube Research & Technologies | 2023-12-31 | 100.0 | Royal Bank Of Canada | 2023-12-31 | 67.0 | Bank Of America Corp | 2023-12-31 | 15.0 | Wells Fargo & Co | 2023-12-31 | 8.0 | Morgan Stanley - Brokerage Accounts | 2023-09-30 | 0.0 | Jpmorgan Chase & Co | 2023-09-30 | 0.0 | Barclays Plc | 2023-09-30 | 0.0 | Ubs Group Ag | 2023-09-30 | 0.0 |
Trxade Fundamentals
| Return On Equity | -31.0 | ||||
| Return On Asset | -0.56 | ||||
| Profit Margin | (2.16) % | ||||
| Operating Margin | (2.63) % | ||||
| Current Valuation | 15.4 M | ||||
| Shares Outstanding | 1.41 M | ||||
| Shares Owned By Insiders | 24.06 % | ||||
| Shares Owned By Institutions | 4.84 % | ||||
| Number Of Shares Shorted | 20.53 K | ||||
| Price To Book | 0.75 X | ||||
| Price To Sales | 0.94 X | ||||
| Revenue | 8.27 M | ||||
| Gross Profit | 4.58 M | ||||
| EBITDA | (6.19 M) | ||||
| Net Income | (13.72 M) | ||||
| Cash And Equivalents | 962.23 K | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 7.1 M | ||||
| Debt To Equity | 0.93 % | ||||
| Current Ratio | 1.32 X | ||||
| Book Value Per Share | 0.60 X | ||||
| Cash Flow From Operations | (2.07 M) | ||||
| Short Ratio | 0.30 X | ||||
| Earnings Per Share | (17.96) X | ||||
| Target Price | 6.75 | ||||
| Beta | 1.93 | ||||
| Market Capitalization | 8.45 M | ||||
| Total Asset | 12.53 M | ||||
| Retained Earnings | (33.25 M) | ||||
| Working Capital | (8.8 M) | ||||
| Current Asset | 1.12 M | ||||
| Current Liabilities | 49 K | ||||
| Annual Yield | 0.27 % | ||||
| Net Asset | 12.53 M |
About Trxade Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trxade Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trxade using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trxade Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Trxade in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Trxade's short interest history, or implied volatility extrapolated from Trxade options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trxade Piotroski F Score and Trxade Altman Z Score analysis. Note that the Trxade Group information on this page should be used as a complementary analysis to other Trxade's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Trxade Stock analysis
When running Trxade's price analysis, check to measure Trxade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trxade is operating at the current time. Most of Trxade's value examination focuses on studying past and present price action to predict the probability of Trxade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trxade's price. Additionally, you may evaluate how the addition of Trxade to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Trxade's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trxade. If investors know Trxade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trxade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.766 | Earnings Share (17.96) | Revenue Per Share 10.827 | Quarterly Revenue Growth 0.043 | Return On Assets (0.56) |
The market value of Trxade Group is measured differently than its book value, which is the value of Trxade that is recorded on the company's balance sheet. Investors also form their own opinion of Trxade's value that differs from its market value or its book value, called intrinsic value, which is Trxade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trxade's market value can be influenced by many factors that don't directly affect Trxade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trxade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trxade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trxade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.